The main objective of the study was to formulate and evaluate oral thin film containing Sumatriptan succinate. The 4 and 5 % w/v HPMC, PVA, CMC films were prepared by solvent casting method. Compatibility of Sumatriptan with polymers was confirmed by FT-IR studies. Films were evaluated for weight variation and thickness showed satisfactory results. Tensile strength and folding endurance of the films were increased with increase in the concentration of polymer due to increase in the elasticity nature of the polymer. Mouth dissolving time and disintegration time of the films were increased with increase in the concentration of the polymer, as more fluid is required to wet the film in the mouth. The presence of disintegrant showed a considerable effect on the disintegration time of the films. Content uniformity study showed that the drug is uniformly distributed in the film. No differences were observed in invitro dissolution of drug from the film I - VI as the film instantly gets wet by dissolution medium. Present study reveals that all the formulated films showed satisfactory film parameters. It can be concluded that, Oral thin film-containing Sumatriptan can be prepared by solvent casting method. 4% w/v of HPMC (FV) film exhibited required tensile strength, folding endurance and disintegration time. The drug release was about 98.5 % in 300 seconds.
Formulation Development and Evaluation of Oral Fast Dissolving Films of Metac...ijtsrd
Metaclopromide HCl is an Anti emetic used to treat nausea, vomiting and to increase gastric motility. The present work aimed at preparing oral fast dissolving films of Metaclopromide HCl with the purpose of developing a dosage form for a very quick onset of action, which is very convenient for administration, without the problem of swallowing and using water. Oral fast dissolving films of Metaclopromide HCl were prepared using HPMC E5, E15 polymers as film forming agents and polyethylene glycol 400 as plasticizer by solvent casting method. FTIR showed that there is no interaction between drug and excipients. Dissolution of prepared fast dissolving oral films of Metaclopromide HCl was performed using USP type II apparatus in pH 6.8 phosphate buffer medium at 50 rpm with temperature being maintained at 37 0.5º C. The films prepared were evaluated for various parameters like thickness, drug content uniformity, weight variation, disintegration time, folding endurance and in vitro drug release and were showed satisfactory results. In conclusion, development of oral fast dissolving oral films using HPMC polymer gives rapid drug delivery and rapid onset of action. Zeenath Ruhy "Formulation Development and Evaluation of Oral Fast Dissolving Films of Metaclopromide HCL" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-1 , December 2019, URL: https://www.ijtsrd.com/papers/ijtsrd29702.pdf Paper URL: https://www.ijtsrd.com/pharmacy/novel-drug-delivery-sys/29702/formulation-development-and-evaluation-of-oral-fast-dissolving-films-of-metaclopromide-hcl/zeenath-ruhy
Oral Dispersible Film is a Novel Drug Delivery System intended to bypass the hepatic first pass metabolism and also many other benefits over the conventional oral dosage forms. It provides the user to administer the drug without the use of water and without ant expertise in administration.
Formulation Development and Evaluation of Oral Fast Dissolving Films of Metac...ijtsrd
Metaclopromide HCl is an Anti emetic used to treat nausea, vomiting and to increase gastric motility. The present work aimed at preparing oral fast dissolving films of Metaclopromide HCl with the purpose of developing a dosage form for a very quick onset of action, which is very convenient for administration, without the problem of swallowing and using water. Oral fast dissolving films of Metaclopromide HCl were prepared using HPMC E5, E15 polymers as film forming agents and polyethylene glycol 400 as plasticizer by solvent casting method. FTIR showed that there is no interaction between drug and excipients. Dissolution of prepared fast dissolving oral films of Metaclopromide HCl was performed using USP type II apparatus in pH 6.8 phosphate buffer medium at 50 rpm with temperature being maintained at 37 0.5º C. The films prepared were evaluated for various parameters like thickness, drug content uniformity, weight variation, disintegration time, folding endurance and in vitro drug release and were showed satisfactory results. In conclusion, development of oral fast dissolving oral films using HPMC polymer gives rapid drug delivery and rapid onset of action. Zeenath Ruhy "Formulation Development and Evaluation of Oral Fast Dissolving Films of Metaclopromide HCL" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-1 , December 2019, URL: https://www.ijtsrd.com/papers/ijtsrd29702.pdf Paper URL: https://www.ijtsrd.com/pharmacy/novel-drug-delivery-sys/29702/formulation-development-and-evaluation-of-oral-fast-dissolving-films-of-metaclopromide-hcl/zeenath-ruhy
Oral Dispersible Film is a Novel Drug Delivery System intended to bypass the hepatic first pass metabolism and also many other benefits over the conventional oral dosage forms. It provides the user to administer the drug without the use of water and without ant expertise in administration.
Thin film drug delivery (Oral dissolve film )Chouthri D
to know about oral dissolving films, ,thin film dds ,oral dissolve films ,oral dispersal film ,api ,advantage for oral thin film ,ingredient using in thin film ,colouring agent used in thin film ,semisolid casting method ,thin film manufacturing mathods ,solvent casting method ,hot melt extrusion ,roiling method ,plasticizer ,water soluble polymers ,comparing between odt and odf ,solid dispersion extrusion ,application of oral dissolving film ,composition of fds,surfactant,saliva stimulating agent,flavouring agent,thi film manufacturing video
Oral Films Development & Manufacturing in India - Current ScenarioSridhar Rudravarapu
This presentation depicts the current status of oral film development and manufacturing in India. Oral film (orodispersible & oromucosal film) is a novel and alternate dosage delivery system with a huge scope for application in the pharma and nutraceuticals industry. This presentation orients the customers at the level of patients, health professionals and manufacturing companies about the oral films product development process, manufacturing aspects, and regulatory steps involved in the approval of these by the drug control authority in India. This presentation aims to briefly cover all the aspects of oral films (orodispersible/oromucosal) development and manufacturing feasibility in India to maximize its application for multiple health and patient compliance benefits -- Sridhar Rudravarapu
Development and Characterisation of Fast Dissolving Oral FilmsPardeep Jangra
For My review article on Fast Dissolving Oral Films, click on this link http://www.ijupbs.com/Uploads/2.%20RPA13140283015.pdf or copy paste this link in browser.
Pardeep Kumar Jangra
ABSTRACT Gliclazide microspheres were prepared by ionotropic gelation method using bioadhesive polymers such as sodium alginate, carbopol 934, carbopol 971, HPMC K4M in different ratios. Totally twelve different formulations of gliclazide were prepared by using the above polymers. The microspheres were characterized for drug content, entrapment efficiency, swelling index, mucoadhesive property by In vitro wash-off test and in-vitro drug release. The results of this investigation indicate that ionic cross linking technique Ionotropic gelation method can be successfully employed to fabricate Model drug microspheres. Micrometric studies revealed that the mean particle size of the prepared microspheres was in the size range of 512-903 μm and are suitable for bioadhesive microspheres for oral administration. The in-vitro mucoadhesive study demonstrated that microspheres of Model drug using sodium alginate along with Carbopol 934 as copolymer adhered to the mucus to a greater extent than the microspheres of Model drug using sodium alginate along with Carbopol 971 and HPMC K4Mas copolymers. Analysis of drug release mechanism showed that the drug release from the formulations followed non-Fickian diffusion and the best fit model was found to be Korsmeyer-Peppas. Based on the results of evaluation tests formulation coded T4 was concluded as best formulation. Keywords: Bioadhesive Microspheres, Gliclazide, Ionotropic gelation method.
Formulation and evaluation of fast dissolving tabletsSURYAKANTVERMA2
The concept of mouth dissolving drug delivery systems (MDDDS) or fast dissolving tablets emerged with an objective to improve patient’s compliance.
These dosage forms rapidly disintegrate and/or dissolve to release the drug as soon as they come in contact with saliva, thus obviating the need for water during administration, an attribute that makes them highly attractive for pediatric and geriatric patients.
Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...IOSR Journals
The concept of mouth dissolving tablets known as MDTs has emerged with an objective to improve patient’s compliance. Methods to improve patient’s compliance have always attracted scientists towards the development of fancy oral drug delivery systems. Among them, mouth dissolving drug delivery systems (MDDDS) have obtained an important position in the market by overcoming previously encountered administration problems and contributing to extension of patent life. These dosage forms rapidly disintegrate in contact with saliva even within <60 seconds, an attribute that makes them highly attractive for paediatric, geriatric, bedridden patients and for active patients who are busy and in travelling may not have access to water. This special dosage form has some prerequisite criteria for formulation and this also involves the use of special techniques for large scale industrial production. The aim of this article is to review the advantages and disadvantages of MDTs, common excipients used in the formulation especially highlighting the use of superdisintegrating agents and taste masking agents in formulation and finally the popular methods used to produce large scale tablets for commercial purpose.
Development and Characterization of Ondansetron Mouth Dispersible Films using...NehaFernandes2
Orodispersible films are solid dosage forms, which disintegrate or dissolve within a few seconds when placed in the oral cavity. In order to overcome the drawback of the conventional ondansetron hydrochloride tablet as antiemetic the ondansetron hydrochloride orodispersible films was formulated by solvent casting method using pullulan and HPMC E15 polymer combination.
Formulation development and invitro evaluation of lamotrigine fast dissolving...SriramNagarajan19
The present study was to formulate and evaluate oral fast dissolving Oral tablet containing Lamotrigine. Present study reveals that all the nine formulated tablet showed satisfactory tablet parameters. It can be concluded that, Oral fast dissolving tablet -containing Lamotrigine can be prepared by direct compression method. 10% CCS (FV) tablet exhibited required disintegration time and dissolution time. The drug release was about 98.7 % in 15min. The accelerated stability studies of the optimized F5 formulation indicates that the formulated oral fast dissolving tablet were unaffected after 3 months storage under accelerated conditions as there were no signs of visually distinguishable changes in appearance, disintegration time and cumulative percentage of drug release. From the present investigation it can be concluded that oral fast dissolving tablet formulation can be a potential novel drug dosage form for pediatric, geriatric and also for general population.
Thin film drug delivery (Oral dissolve film )Chouthri D
to know about oral dissolving films, ,thin film dds ,oral dissolve films ,oral dispersal film ,api ,advantage for oral thin film ,ingredient using in thin film ,colouring agent used in thin film ,semisolid casting method ,thin film manufacturing mathods ,solvent casting method ,hot melt extrusion ,roiling method ,plasticizer ,water soluble polymers ,comparing between odt and odf ,solid dispersion extrusion ,application of oral dissolving film ,composition of fds,surfactant,saliva stimulating agent,flavouring agent,thi film manufacturing video
Oral Films Development & Manufacturing in India - Current ScenarioSridhar Rudravarapu
This presentation depicts the current status of oral film development and manufacturing in India. Oral film (orodispersible & oromucosal film) is a novel and alternate dosage delivery system with a huge scope for application in the pharma and nutraceuticals industry. This presentation orients the customers at the level of patients, health professionals and manufacturing companies about the oral films product development process, manufacturing aspects, and regulatory steps involved in the approval of these by the drug control authority in India. This presentation aims to briefly cover all the aspects of oral films (orodispersible/oromucosal) development and manufacturing feasibility in India to maximize its application for multiple health and patient compliance benefits -- Sridhar Rudravarapu
Development and Characterisation of Fast Dissolving Oral FilmsPardeep Jangra
For My review article on Fast Dissolving Oral Films, click on this link http://www.ijupbs.com/Uploads/2.%20RPA13140283015.pdf or copy paste this link in browser.
Pardeep Kumar Jangra
ABSTRACT Gliclazide microspheres were prepared by ionotropic gelation method using bioadhesive polymers such as sodium alginate, carbopol 934, carbopol 971, HPMC K4M in different ratios. Totally twelve different formulations of gliclazide were prepared by using the above polymers. The microspheres were characterized for drug content, entrapment efficiency, swelling index, mucoadhesive property by In vitro wash-off test and in-vitro drug release. The results of this investigation indicate that ionic cross linking technique Ionotropic gelation method can be successfully employed to fabricate Model drug microspheres. Micrometric studies revealed that the mean particle size of the prepared microspheres was in the size range of 512-903 μm and are suitable for bioadhesive microspheres for oral administration. The in-vitro mucoadhesive study demonstrated that microspheres of Model drug using sodium alginate along with Carbopol 934 as copolymer adhered to the mucus to a greater extent than the microspheres of Model drug using sodium alginate along with Carbopol 971 and HPMC K4Mas copolymers. Analysis of drug release mechanism showed that the drug release from the formulations followed non-Fickian diffusion and the best fit model was found to be Korsmeyer-Peppas. Based on the results of evaluation tests formulation coded T4 was concluded as best formulation. Keywords: Bioadhesive Microspheres, Gliclazide, Ionotropic gelation method.
Formulation and evaluation of fast dissolving tabletsSURYAKANTVERMA2
The concept of mouth dissolving drug delivery systems (MDDDS) or fast dissolving tablets emerged with an objective to improve patient’s compliance.
These dosage forms rapidly disintegrate and/or dissolve to release the drug as soon as they come in contact with saliva, thus obviating the need for water during administration, an attribute that makes them highly attractive for pediatric and geriatric patients.
Mouth dissolving tablets- A unique dosage form curtailed for special purpose:...IOSR Journals
The concept of mouth dissolving tablets known as MDTs has emerged with an objective to improve patient’s compliance. Methods to improve patient’s compliance have always attracted scientists towards the development of fancy oral drug delivery systems. Among them, mouth dissolving drug delivery systems (MDDDS) have obtained an important position in the market by overcoming previously encountered administration problems and contributing to extension of patent life. These dosage forms rapidly disintegrate in contact with saliva even within <60 seconds, an attribute that makes them highly attractive for paediatric, geriatric, bedridden patients and for active patients who are busy and in travelling may not have access to water. This special dosage form has some prerequisite criteria for formulation and this also involves the use of special techniques for large scale industrial production. The aim of this article is to review the advantages and disadvantages of MDTs, common excipients used in the formulation especially highlighting the use of superdisintegrating agents and taste masking agents in formulation and finally the popular methods used to produce large scale tablets for commercial purpose.
Development and Characterization of Ondansetron Mouth Dispersible Films using...NehaFernandes2
Orodispersible films are solid dosage forms, which disintegrate or dissolve within a few seconds when placed in the oral cavity. In order to overcome the drawback of the conventional ondansetron hydrochloride tablet as antiemetic the ondansetron hydrochloride orodispersible films was formulated by solvent casting method using pullulan and HPMC E15 polymer combination.
Formulation development and invitro evaluation of lamotrigine fast dissolving...SriramNagarajan19
The present study was to formulate and evaluate oral fast dissolving Oral tablet containing Lamotrigine. Present study reveals that all the nine formulated tablet showed satisfactory tablet parameters. It can be concluded that, Oral fast dissolving tablet -containing Lamotrigine can be prepared by direct compression method. 10% CCS (FV) tablet exhibited required disintegration time and dissolution time. The drug release was about 98.7 % in 15min. The accelerated stability studies of the optimized F5 formulation indicates that the formulated oral fast dissolving tablet were unaffected after 3 months storage under accelerated conditions as there were no signs of visually distinguishable changes in appearance, disintegration time and cumulative percentage of drug release. From the present investigation it can be concluded that oral fast dissolving tablet formulation can be a potential novel drug dosage form for pediatric, geriatric and also for general population.
Development and pharmaceutical evaluation of oral fast dissolving thin film o...Madiha Mushtaque
The current study focused on the development, optimization and pharmaceutical evaluation of a mouth dissolving film of Escitalopram 5mg. The designing and optimization of the formulations have been carried out through
Design-Expert ® Ver. 9, using central composite response surface methodology. The software generated six optimized
formulations have been fabricated via solvent casting method incorporated with HPMC and PEG 400 as Plasticizer. The
developed formulations were assessed for various quality attributes including weight variation, drug-excipients
interaction, dryness/ tack test, thickness, percent elongation, swelling index, disintegration, folding endurance, surface
pH, content uniformity, assay, moisture uptake, stability, and organoleptic properties. A validated spectrophotometric
method has been used to ascertain drug content. The formulations were subjected for stability studies for six months in
accordance with ICH accelerated stability studies guidelines. No stability issue has been observed. All the test
formulations have shown satisfactory in vitro release of escitalopram whereas most promising results have been
exhibited by F5 and F6 formulations. The study concluded that a unique, novel, safe and stable formulation of oral fast
dissolving thin films of escitalopram can be formulated with ease. The preparation method was simple and reproducible
with scale-up tendency so that it can fulfill the need of the commercial manufacturing process.
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...Valentyn Mohylyuk
Suspension of microparticles in an easy-to-swallow liquid is one approach to develop sustained-release formulations for children and patients with swallowing difficulties. However, to date production of sustained-release microparticles at the industrial scale has proven to be challenging. The aim of this investigation was to develop an innovative concept in coating sustained-release microparticles using industrial scalable Wurster fluidised bed to produce oral liquid suspensions. Microcrystalline cellulose cores (particle size <150 μm) were coated with Eudragit® NM 30 D and Eudragit® RS/RL 30 D aqueous dispersions using a fluidised bed coater. A novel approach of periodic addition of a small quantity (0.1% w/w) of dry powder glidant, magnesium stearate, to the coating chamber via an external port was applied throughout the coating process. This method significantly increased coating production yield from less than 50% to up to 99% compared to conventional coating
process without the dry powder glidant. Powder rheology tests showed that dry powder glidants increased the tapped density and decreased the cohesive index of coated microparticles. Reproducible microencapsulation of a highly water-soluble drug, metoprolol succinate, was achieved, yielding coated microparticles less than 200 μm in size with 20-h sustained drug release, suitable for use in liquid suspensions. The robust, scalable technology presented in this study offers an important solution to the long-standing challenges of formulating sustained-release dosage forms suitable for children and older people with swallowing difficulties.
2018.09.07. Development of multi-dose oral sustained release suspensions for ...Valentyn Mohylyuk
The present study was aimed at the development of a re-dispersible multi-dose suspension based on coated microparticles to ensure easy swallowing and sustained release of metoprolol succinate. To provide sustained release of metoprolol succinate, the microparticles were prepared by drug loading and Eudragit® NM coating in a fluid-bed coater. Compositions of the liquid suspension vehicle were selected to reduce solubility of metoprolol succinate. The effect of vehicle composition and suspension storage time at RT on drug leaching into the suspension vehicle and on the drug release profile were investigated. The approach allowed a re-dispersible multi-dose suspension of metoprolol microparticles which, after one month’s storage, displayed negligible drug leaching into the suspension vehicle and a sustained release profile comparable to the profile before storage.
Formulation and evaluation of mouth dissolving film containing antiemetic dru...siddhant thakur
The final presentation on the research topic of "FORMULATION AND EVALUATION OF MOUTH DISSOLVING FILM CONTAINING ANTIEMETIC DRUG FOR THE TREATMENT OF MOTION SICKNESS"
This presentation includes the Introduction about MDFs, Literature reviews, Statement of the research problem, Objectives of the study, Plan of research work, Drug selections, Preformulation studies, Design expert 11, Preparation of MDFs and Evaluations, Optimization of formulations and final conclusion
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HClMohammad Adil
Conventional ocular drug delivery system i.e., eye drops, ointments, gels etc., had become less popular pertaining to their disadvantages like evaporation by tears, pre-corneal loss, drug metabolism, drug-protein interaction, drainage, sticking of eye lids, induced lacrimation, poor patient compliance, systemic side effect and blurred vision etc. That’s why fundamentals of controlled release by means of ocular inserts were utilized to increase problem pre-corneal drug residence time.
This project title “Formulation and Evaluation of Ocuserts of Ciprofloxacin HCl” revealed following results:
Compatibility study using FTIR was performed to check the compatibility of drug with various excipient. Characteristics peaks obtained with pure drug were compared with that produced with different excipients that confirmed the compatibility of drug with excipients.
Ocusert of Ciprofloxacin HCl was prepared using different material i.e., PVP K-30, PVA, PEG 400 and glycerin.
Prepared ocuserts were evaluated for various parameters viz., percentage moisture loss, percentage moisture absorbs, thickness, weight variation, drug content and In-vitro diffusion.
The percentage (%) moisture absorption and loss of ocular insert were found to be 26% and 27% respectively.
The thickness of ocular insert was found to be uniformed and its mean while measuring at different points was found to be 0.124mm.
The weight of ocular inserts was found to be in the range of 12.2 - 12.6mg which indicated decent distribution of the drug, polymer and plasticizer.
The drug content of ocular insert was found to be 99.89%.
Percentage drug release from Ciprofloxacin HCl Ocusert was found to be 41.969% in 8 hr.
It was concluded that prepared Ocusert of Ciprofloxacin HCl could be a better alternative to conventional ocular formulations that retained on ocular surface for longer duration and released drug in controlled manner.
Background: The main objective of present research work is to formulate the Carbamazepine Fast Dissoving tablets. Carbamazepine, an
antiepileptic, belongs to BCS Class-II and used to control some types of seizures in the treatment of epilepsy and Neuropathic Pain by
blocking use-dependent sodium channels. Methods: The Fast Dissoving tablets of Carbamazepine were prepared employing different
concentrations of Crospovidone and Croscarmellose sodium in different combinations as a Sperdisintegrants by Direct Compression technique
using 32
factorial design. The concentration of Crospovidone and Croscarmellose sodium was selected as independent variables, X1
and X2 respectively whereas, wetting time, Disintegration time, t
50% ,t90%were selected as dependent variables. Results and Discussion:
Totally nine formulations were designed and are evaluated for hardness, friability, thickness, Assay, Wetting time, Disintegration time, Invitro
drug release. From the Results concluded that all the formulation were found to be with in the Pharmacopoeial limits and the In-vitro
dissolution profiles of all formulations were fitted in to different Kinetic models, the statistical parameters like intercept (a), slope (b) &
regression coefficient (r) were calculated. Polynomial equations were developed for Wetting time, Disintegration time, t50%, t90%. Validity of
developed polynomial equations were verified by designing 2 check point formulations (C1
, C2
). According to SUPAC guidelines the
formulation (F5
) containing combination of 9.375% Crospovidone and 9.375% Croscarmellose, is the most similar formulation (similarity factor
f
2
=82.675, dissimilarity factor f1
= 2.049 & No significant difference, t= 0.041) to marketed product (TEGRETOL-100). Conclusion: The
selected formulation (F5
) follows First order, Higuchi’s kinetics, mechanism of drug release was found to be Non-Fickian Diffusion (n= 0.665).
KEYWORDS: Carbamazepine, 3
2Factorial Design, Crospovidone , croscarmellose Sodium, Wetting Time, Disintegration Time.
Formulation Development and Evaluation of Mouth Dissolving Film of Ziprasidon...ijtsrd
The primary objective of this work was to develop a mouth dissolving film with Ziprasidone HCI, along with bioenhancer quercetin and basic ingredients like polymers, plasticizers, sweetener, saliva stimulating agent and flavor. The films were prepared by solvent casting I method. Quercetin enhances dissolution of drug which results in increase in CDR upto 99 . HPMC E5 cps, which was not able to impart thickness to the film, HPMC E15 shown good flexibility. The plasticizer propylene glycol which was not able to impart flexibility and folding endurance to the film. PEG 400 produced good folding endurance, tensile strength and percent elongation. The optimized formulation F3 was shown good mouth feel, folding endurance, instant drug release as well as good mechanical properties. The F3, shown less disintegration time of 31 seconds and 95 drug released within 3 minutes. Therefore it was concluded that rapid drug release was achieved for immediate onset of action using quercetin as natural bioenhancer which is beneficial and gives maximum drug release when compared to conventional dosage form. Jaydeep Jadhav "Formulation Development and Evaluation of Mouth Dissolving Film of Ziprasidone Using Natural Bioenhancer" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-5 , August 2022, URL: https://www.ijtsrd.com/papers/ijtsrd50464.pdf Paper URL: https://www.ijtsrd.com/pharmacy/pharmaceutics/50464/formulation-development-and-evaluation-of-mouth-dissolving-film-of-ziprasidone-using-natural-bioenhancer/jaydeep-jadhav
The Formulation of Pacing (Costus speciosus) Extract Tablet By Using Avicel®P...UniversitasGadjahMada
Pacing (Costus speciosus) is an herbaceous plant that is native to Indonesia and it can be used as a male contraceptive due to spermatogenesis inhibition. The purpose of this study is to find out the composition of optimum Avicel PH 200® as the filler-binder and amylum as the disintegration agent and to find out the variations on physical properties of the powder and tablet. Tablets of Costus speciosus extract (CS tablet) were produced by direct compression in 8 runs based on Simplex Lattice Design (SLD) from Design Expert 7.1.5. Evaluation on physical properties of powder included tapping index, water absorption, and moisture content, while evaluation on the physical properties of tablet included hardness, friability, and disintegration time. The results showed that the variation in the composition between Avicel® PH 200 as the filler-binder and amylum as the disintegration agent had a significant effect on the friability of CS tablet, in which the combination of both materials can increase the friability of the tablet. The optimum formula of CS tablet had a composition of Avicel® PH 200 by 462.5mg and amylum by 37.5mg contained in each tablet.
The oral fast-dissolving film is an advanced, patient compliant and novel delivery system. The acceptance of this ingenious dosage form is increasing day by day due to its several comparative advantages of being cost-benefit, rapid dissolving without water aid, as well as greatly compliant to both geriatric and pediatric patients in emergency conditions and specific diseases. Moreover, it is a worthwhile dosage form for the drug experiencing pre-systemic metabolism and lesser bioavailability. This review article covers history, advantages, disadvantages, limitations, ideal properties, classification, formulation consideration, method of manufacturing, quality parameters both in-vitro and in-vivo, advancement in technology, commercial trends and literature review of the previous work for oral fast dissolving films. It can be concluded that it one of the fastest-growing dosage forms holding a lot of potentials especially for commercial use due to its unique characteristics, novel attributes, competitive standing, and cost-adequacy
Almost Exact Procedure is provided in each & every slide ..
Thanks & Best Regards
Anurag Pandey (B.Pharm)
Contact :- anurag.dmk05@gmail.com (Facebook & Gmail)
Formulation, characterization and Evaluation of Transdermal Film Containing N...SriramNagarajan15
Transdermal drug delivery system has numerous advantages over the more traditional drug delivery systems. This includes high bioavailability, steady drug plasma concentration, absence of first pass hepatic metabolism effect. Transdermal film is an adhesive film that has a coating of a drug that is placed on the skin to deliver a specific dose of the drug into the bloodstream over a period. The aim of present study an attempt was made to design the transdermal drug delivery system of naproxen with Ethyl Cellulose polymer in various concentrations. Transdermal films were prepared by solvent casting method by using Dibutylpthalate as plasticizer. The prepared films were characterized in physical appearance, thickness, drug content, weightvaration, Folding endurance, percentage moisture uptake and in-vitro release study.
A new RP -HPLC method development and validation for simultaneous estimation ...SriramNagarajan19
A simple, accurate, precise method was developed for the simultaneous estimation of the Aspirin and Omeprazole in Tablet dosage form. Chromatogram was run through Discovery 250 x 4.6 mm, 5m. Mobile phase containing Buffer and Acetonitrile in the ratio of 70:30 v/v was pumped through column at a flow rate of 1 ml/min. Temperature was maintained at 30°C. Optimized wavelength for Aspirin and Omeprazole was 241 nm. Retention time of Aspirin and Omeprazole were found to be 2.454 min and 3.168 min %RSD of the Aspirin and Omeprazole were and found to be 1.1 and 0.8 respectively. Percentage recovery was obtained as 99.50% and 99.57%for Aspirin and Omeprazole. LOD, LOQ values were obtained from regression equations of Aspirin and Omeprazole were 0.26ppm, 0.80ppm and 0.06ppm, 0.17ppm respectively. Regression equation of Aspirin is y = 3524x + 3853, and of Omeprazole is y = 10438x+542.2.
Nutrease powder; a natural plant based nutritional shake with co-factors & co...SriramNagarajan19
Nutrease powder is an effective natural vitamin and minerals Nutritional supplementation to improve metabolism. Nutrease powder just ½ serving (1 scoop) Provides 150 calories,18 grams of protein, 12 grams of fiber, and 1 gram of sugar per day. Nutrease powder Supports effective weight management, Reduces hunger and cravings, Promotes energy and positive mood, Promotes loss of fat and preservation of lean body mass, Improves metabolism and insulin sensitivity. This article reviews the current available scientific literature regarding the effect of nutrease powder as an effective supplementation for daily energy needs.
Analytical method development and validation for the estimation of quinapril ...SriramNagarajan19
A simple and selective LC method is described for the determination of Quinapril and Tolcapone tablet dosage forms. Chromatographic separation was achieved on a c18 column using mobile phase consisting of a Mixed Phosphate buffer (KH2PO4 +K2HPO4): Acetonitrile 40:60, with detection of 239 nm. Linearity was observed in the range 50 - 150 µg /ml for Quinapril (r2 =0.995) and 62.5- 187.5µg /ml for Tolcapone (r2 =0.999) for the amount of drugs estimated by the proposed methods was in good agreement with the label claim.
The proposed methods were validated. The accuracy of the methods was assessed by recovery studies at three different levels. Recovery experiments indicated the absence of interference from commonly encountered pharmaceutical additives. The method was found to be precise as indicated by the repeatability analysis, showing %RSD less than 2. All statistical data proves validity of the methods and can be used for routine analysis of pharmaceutical dosage form.
Method development and validation of simultaneous estimation of paracetamol &...SriramNagarajan19
A drug may be defined as a substance meant for diagnosis, cure, mitigation, prevention or treatment of diseases in human beings or animals or for alternating any structure or function of the body of human being or animals. Pharmaceutical chemistry is a science that makes use of general laws of chemistry to study drugs i.e. their preparation, chemical natures, composition, structure, influence on an organism and studies the physical and chemical properties of drugs, the methods of quality control and the conditions of their storage etc. the family of drugs may be broadly classified as.
1. Pharmacodynamic agents.
2. Chemotherapeutic agents.
It is necessary to find the content of each drug either in pure or single, combined dosage forms for purity testing. It is also essential to know the concentration of the drug and it’s metabolites in biological fluids after taking the dosage form for treatment.
The scope of developing and validating analytical methods is to ensure a suitable method for a particular analyte more specific, accurate and precise. The main objective for that is to improve the conditions and parameters, which should be followed in the development and validation.
WELLIA-R tablets; helps to protect brain tissue in cerebral edemaSriramNagarajan19
Boswellia serrate extract in Wellia- R gained significant importance in treatment of cerebral edema in patients with brain tumors, colon cancer, lung cancer, blood cancer, skin cancer, breast cancer, renal cancer, fibro sarcoma, prostate cancer and pancreatic cancer. The medicinal properties of Boswellia serrate extract in Wellia- R have been known and utilized since antiquity. Its current potential as an anti inflammatory and anticancer agent are being investigated and hold great promise. This article reviews the current available scientific literature regarding the effect of wellia-R tablets, from Boswellia serrate extract that Provides long lasting cerebral protection in brain tumor patients
Formulation and invivo evaluation of mucoadhesive microspheres embedded clero...SriramNagarajan19
In this study an attempt was made to prepare mucoadhesive microcapsules of Clerodendrum phlomidis extract using alginate polymers for prolonged release. Encapsulation of extract into sodium alginate polymer was done by ionic-gelation technique. In vivo testing of the mucoadhesive microcapsules in diabetic albino rats demonstrated significant antidiabetic effect of extract. The hypoglycemic effect obtained by mucoadhesive microcapsules was for more than 16 h whereas plain CP extract produced an antidiabetic effect for only 4 h suggesting that mucoadhesive microcapsules are a valuable system for the long term delivery of CP extract. In-vivo data obtained over a 120-h period indicate that CP extract loaded alginate microspheres from batch F7 showed the better glycemic control than control and a commercial brand of the drug.
Brian stroke memory impairment and treatment strategiesSriramNagarajan19
A brain stroke occurs when one of the brain parts are deprived form oxygen-rich blood due to various mechanism. Usually a brain stroke occurs when one of the arteries is blocked either because of narrowing of small arteries with in the brain or the hardening of the arteries that lead to atherosclerosis strokes can be either ischemic (85%) or Hemorrhagic (15%). Forget fullness is a common complaint among older people. Age –related memory changes are not the same thing as dementia. Preventing memory loss is by exercise regularly staying social, manage stress, get plenty of sleep and don’t smoke. Eat plenty of fruits and vegetable and take food contain antioxidant in abundance; will reduce your risk of stroke. Walking regularly is an easy to fight memory loss and also brain exercises to prevent loss and boost brainpower. Research is going no to enhance memory power in brain in patient with brain stroke.
A new analytical method development and validation for the estimation of lenv...SriramNagarajan19
A simple and selective LC method is described for the determination of Lenvatinib dosage forms. Chromatographic separation was achieved on a c18 column using mobile phase consisting of a mixture of Phosphate buffer (KH2PO4): Acetonitrile (80:20) with detection of 240nm. Linearity was observed in the range 60-140 µg /ml for Lenvatinib (r2 =0.996) for the amount of drug estimated by the proposed methods was in good agreement with the label claim.
The proposed methods were validated. The accuracy of the methods was assessed by recovery studies at three different levels. Recovery experiments indicated the absence of interference from commonly encountered pharmaceutical additives. The method was found to be precise as indicated by the repeatability analysis, showing %RSD less than 2. All statistical data proves validity of the methods and can be used for routine analysis of pharmaceutical dosage form.
A new analytical method development and validation for the simultaneus estima...SriramNagarajan19
A simple and selective LC method is described for the determination of LEDIPASVIR and SOFOSBUVIR in tablet dosage forms. Chromatographic separation was achieved on a c18 column using mobile phase consisting of a mixture of Mixed Phosphate Buffer:ACN (55:45) with detection of 213 nm. Linearity was observed in the range 60-140 µg/ml for LEDIPASVIR oxalate (r2 =0.999) and 6-14 µg /ml for SOFOSBUVIR (r2 =0.996) for the amount of drugs estimated by the proposed methods was in good agreement with the label claim.
The proposed methods were validated. The accuracy of the methods was assessed by recovery studies at three different levels. Recovery experiments indicated the absence of interference from commonly encountered pharmaceutical additives. The method was found to be precise as indicated by the repeatability analysis, showing %RSD less than 2. All statistical data proves validity of the methods and can be used for routine analysis of pharmaceutical dosage form.
A new analytical method development and validation for the simultaneus estima...SriramNagarajan19
A simple and selective LC method is described for the determination of Ibuprofen and Tramadol in tablet dosage forms. Chromatographic separation was achieved on a c18 column using mobile phase consisting of a mixture of 60 volumes of Triethylamine buffer, 40 volumes of acetonitrile with detection of 227 nm. Linearity was observed in the range 50-150 µg/ml for Ibuprofen (r2 =0.983) and 50-150 µg /ml for Tramadol (r2 =0.985) for the amount of drugs estimated by the proposed methods was in good agreement with the label claim.
The proposed methods were validated. The accuracy of the methods was assessed by recovery studies at three different levels. Recovery experiments indicated the absence of interference from commonly encountered pharmaceutical additives. The method was found to be precise as indicated by the repeatability analysis, showing %RSD less than 2. All statistical data proves validity of the methods and can be used for routine analysis of pharmaceutical dosage form.
Method development and validation of escitalopram and estizolam in tablet dos...SriramNagarajan19
A simple and selective LC method is described for the determination of Escitalopram oxalate and Etizolam in tablet dosage forms. Chromatographic separation was achieved on a c18 column using mobile phase consisting of a mixture of 30 volumes of ammonium acetate buffer, 40 volumes of acetonitrile and 30 volumes of Methanol with detection of 238 nm. Linearity was observed in the range 60-140 µg/ml for Escitalopram oxalate (r2 =0.999) and 6-14 µg /ml for Etizolam (r2 =0.996) for the amount of drugs estimated by the proposed methods was in good agreement with the label claim.
The proposed methods were validated. The accuracy of the methods was assessed by recovery studies at three different levels. Recovery experiments indicated the absence of interference from commonly encountered pharmaceutical additives. The method was found to be precise as indicated by the repeatability analysis, showing %RSD less than 2. All statistical data proves validity of the methods and can be used for routine analysis of pharmaceutical dosage form.
Analytical method development and validation for the estimation of aspirin an...SriramNagarajan19
A simple and selective LC method is described for the determination of Aspirin and Omeprazole in tablet dosage forms. Chromatographic separation was achieved on a c18 column using mobile phase consisting of a mixture of 30 volumes of ammonium acetate buffer, 40 volumes of acetonitrile and 30 volumes of Methanol with detection of 233 nm. Linearity was observed in the range 18-42 µg/ml for Aspirin (r2 =0.983) and 6-14 µg /ml for Omeprazole (r2 =0.970) for the amount of drugs estimated by the proposed methods was in good agreement with the label claim. The proposed methods were validated. The accuracy of the methods was assessed by recovery studies at three different levels. Recovery experiments indicated the absence of interference from commonly encountered pharmaceutical additives. The method was found to be precise as indicated by the repeatability analysis, showing %RSD less than 2. All statistical data proves validity of the methods and can be used for routine analysis of pharmaceutical dosage form.
A new analytical method development and validation for the simultaneus estima...SriramNagarajan19
A simple and selective LC method is described for the determination of Albuterol and Ipratropium Bromide in tablet dosage forms. Chromatographic separation was achieved on a c18 column using mobile phase consisting of a mixture of 80 volumes of methanol and 20 volumes of water with detection of 239 nm. Linearity was observed in the range 36-84 µg /ml for Albuterol (r2 =0.996) and 6-14 µg /ml for Ipratropium Bromide (r2 =0.997) for the amount of drugs estimated by the proposed methods was in good agreement with the label claim.
The proposed methods were validated. The accuracy of the methods was assessed by recovery studies at three different levels. Recovery experiments indicated the absence of interference from commonly encountered pharmaceutical additives. The method was found to be precise as indicated by the repeatability analysis, showing %RSD less than 2. All statistical data proves validity of the methods and can be used for routine analysis of pharmaceutical dosage form.
Formulation and evaluation of rosiglitazone nanosuspensionSriramNagarajan19
The main aim of this study is to formulate and evaluate Rosiglitazone Nano suspension. Nano suspensions are colloidal dispersion of Nano sized drug particles stabilized by surfactants. They can also be defined as a biphasic system consisting of pure drug particles dispersed in an aqueous vehicle in which the diameter of the suspended particle is less than 1micro meter in size. Rosiglitazone is an oral rapid and short –acting anti-diabetic drug from the sulfonylurea class. It is classified as a second generation sulfonylurea, which means that it undergoes enter hepatic circulation. Rosiglitazone Nano suspension was prepared by precipitation technique. After preparation of Nano suspension various characterization studies were done such as drug content, %yield, FTIR, DSC, TEM, and Invitro drug release.PVPK30,polaxomer are used as stabilizers. From the dissolution study F4 formulation which containts PVPK30 as stabilizer was considered as optimized formulation. It showed maximum drug release at 30min.FTIR and DSC studies revealed that good stability in dispersion.
Effect of hydrophilic polymers on solubility of some antihypertentives drugs ...SriramNagarajan19
The main aim of the present study is to carried out to enhance solubility of Felodipine. Felodipine.was selected as model drug and different carriers like Vitamin-E, Polyethylene Glycol 8000, Polyvinyl pyrrolidone K-30 were used in drug to carrier ratio 1:1, 1:2, 1:4 by weight respectively. Solid dispersions were prepared by physical mixing method and solvent evaporation method. Solid dispersions were evaluated by drug content, in-vitro release, FT-IR, DSC and XRD. The obtained data of solid dispersion prepared by solvent evaporation method were compared with physical mixing method. The result showed decrease in melting point change from crystalline to amorphous form and improved dissolution rate as compared to physical mixing as well as pure Felodipine. The finding of present study proposes that solid dispersion approach is beneficial in enhancing solubility of drug and bioavailability as well.
A review on plants act on both antidiabetic and antihyperlipidemic plantsSriramNagarajan19
Since ancient times, plants have been an exemplary source of medicine. Ayurveda and other Indian literature mentioned the use of plants in treatment of various human ailments. Medical plants play an important role in the management of diabetes mellitus especially in developing countries where resources are meager. Oral hypoglycemic agents like sulphonylureas and biguanides are still the major players in the management of the disease but there is growing interest in herbal remedies due to the side effects associated with the oral hypoglycemic agents. Herbal medicines have been the highly esteemed source of medicine throughout human history. Hyperlipidemia has been ranked as one of the greatest risk factors contributing to prevalence and severity of coronary heart diseases. Hyperlipidemia is a condition when abnormally high levels of lipids i.e. the fatty substances are found in the blood. Hypolipidemic drugs are extensively used as prophylactic agents to prevent such atherosclerosis induced disorders. But these hypolipidemic drugs are not free from adverse effects. Many plant derivatives and domestic remedies have been screened for their hypolipidemic action. More than 70 medicinal plants have been documented to have significant hypolipidemic action. During the last decade, an increase in the use of medicinal plants has been observed in metropolitan areas of developed countries. Medicinal plants play a major role in diabetes and hypolipidemic activity. The advantages of herbal medicines reported are effectiveness, safety, affordability and acceptability, this review focus on diabeties and hyperlipidemia and the role of plants used for the treatment of diabeties and hyperlipidemia.
FORMULATION AND CHARACTERISATION OF TRANSDERMAL PATCHES OF PERINDOPRILSriramNagarajan19
Transdermal drug delivery system (TDDS) has been an increased interest in the drug administration via the skin for both local therapeutic effects on diseased skin (topical delivery) as well as for systemic delivery of drugs. The skin as a site of drug delivery, has a number of significant advantages over many other routes of drug administration, including the ability to avoid problems of gastric irritation, pH and emptying rate effects, avoid hepatic first-pass metabolism thereby increasing the bioavailability of drug, reduce the risk of systemic side effects by minimizing plasma concentrations compared to oral therapy, provide a sustained release of drug at the site of application; rapid termination of therapy by removal of the device or formulation, the reduction of fluctuations in plasma levels of drugs, and avoid pain associated with injections. The transdermal delivery can also eliminate pulsed entry into the systemic circulation, which might often cause undesirable side effects. Main objective of formulating the transdermal system was to prolong the drug release time, reduce the frequency of administration and to improve patient compliance. In the present study, five formulations were prepared using single polymer in different ratios, along with plasticizers and penetration enhancer. Finally it was concluded that Some formulations show formation of brittle patch due to insufficient amount of polymer and in some patches texture of patch is not elegant due to plasticizer concentration for patch preparation. So by increasing concentration of polymer and plasticizer, finally formulation-5 was considered as optimized formula for preparing transdermal patch of Perindopril, where it shown best drug release profile.
Intercontinental journal of pharmaceutical Investigations and ResearchSriramNagarajan19
Anti-inflammatory activity of the ethanolic extract of Portulaca quadrifida Linn. was studied in wister rats using the carrageenan induced left hind paw edema, carrageenan induced pleurisy and cotton pellet induced granuloma model. The ethanolic extract (200 mg/kg, p.o.,) produced the inhibition of carrageenan induced rat paw edema. It also showed an inhibitory effect on leukocyte migration and a reduction on the pleural exudates as well as reduction on the granuloma weight in the cotton pellet granuloma method. The results indicated that the ethanolic extract produced significant (P<0.001) anti-inflammatory activity when compared with the standard and untreated control.
ANTI-BACTERIAL ACTIVITY OF EXTRACTS OF TACHYSPERMUM AMMI FRUITSSriramNagarajan19
This study was carried out with an objective to investigate the antibacterial activity of Tachyspermum ammi fruits extracts. In the present study, the anti-bacterial activity of aqueous and ethanolic extracts of Tachyspermum ammi fruits was evaluated for potential antimicrobial activity against medically important bacterial and fungal strains. The antimicrobial activity was determined using agar disc diffusion method. The antibacterial and antifungal activities of extracts were tested against Gram-positive—Staphylococcus aureus and Gram-negative—Escherichia coli human pathogenic bacteria. Zone of inhibition of extracts were compared with that of different standard drugs. The results showed that the remarkable inhibition of the bacterial growth was shown against the tested organisms. The phytochemical analyses of the plants were carried out. The antibacterial activity of the Tachyspermum ammi fruits was due to the presence of various secondary metabolites. Hence, these plants can be used to discover bioactive natural products that may serve as leads in the development of new pharmaceuticals research activities.
Live Longer, Stay healthy, Feel better with AstashinecapsulesSriramNagarajan19
ASTASHINE capsule contains natural astaxanthin from Haematococcus pluvialis Astaxanthin has exceptional antioxidant activity to combat singlet oxygen when compared to other antioxidants. In particular, Astaxanthin can be used to defend against singlet oxygen damage, which are especially susceptible to aging effects.
In this study, Astaxanthin extracted from Haematococcus microalgae powerfully quenched singlet oxygen. Results show that the quenching effect of Astaxanthin is 800 times greater than coenzyme Q10. Astaxanthin was also about 75 times greater than alpha lipoic acid, about 550 times greater than green tea catechins and about 6000 times greater than Vitamin C.the present Article reviews the role of ASTASHINE capsules as World’s most powerful Antioxidant and Anti-aging Nutrient.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
Formulation and evaluation of sumatriptan oral thin films
1. Ashok K A et al, ICJPIR 2016, 3(1), 11-21
www.icjpir.com
~11~
Available online at www.icjpir.com ISSN: 2349-5448
Intercontinental journal of pharmaceutical
Investigations and Research
ICJPIR |Volume 3 | Issue 1 | Jan – Mar- 2016 Research Article
Formulation and evaluation of sumatriptan oral thin films
M. Sambasiva Rao, A. Sunil Kumar Reddy, A. Ashok Kumar
Professor & HOD OF Vijaya College of pharmacy, Munaganur (village), Hayathnagar (Mandal),
Ranga redy (District), Pin-501511.
Corresponding Author: A. Ashok Kumar
Email: ashok576@gmail.com
ABSTRACT
The main objective of the study was to formulate and evaluate oral thin film containing Sumatriptan succinate.
The 4 and 5 % w/v HPMC, PVA, CMC films were prepared by solvent casting method. Compatibility of
Sumatriptan with polymers was confirmed by FT-IR studies. Films were evaluated for weight variation and
thickness showed satisfactory results. Tensile strength and folding endurance of the films were increased with
increase in the concentration of polymer due to increase in the elasticity nature of the polymer. Mouth
dissolving time and disintegration time of the films were increased with increase in the concentration of the
polymer, as more fluid is required to wet the film in the mouth. The presence of disintegrant showed a
considerable effect on the disintegration time of the films. Content uniformity study showed that the drug is
uniformly distributed in the film. No differences were observed in invitro dissolution of drug from the film I -
VI as the film instantly gets wet by dissolution medium. Present study reveals that all the formulated films
showed satisfactory film parameters. It can be concluded that, Oral thin film-containing Sumatriptan can be
prepared by solvent casting method. 4% w/v of HPMC (FV) film exhibited required tensile strength, folding
endurance and disintegration time. The drug release was about 98.5 % in 300 seconds.
INTRODUCTION
Oral Thin Films
Fast dissolving oral films (FDOFs) or Oral
wafers or Oral strips (OS) or sublingual strips or
oral thin films (OTF) are the most advanced form
of oral solid dosage form due to more flexibility
and comfort. It improve the efficacy of APIs by
dissolving within minute in oral cavity after the
contact with saliva without chewing and no need of
water for administration. It gives quick absorption
and instant bioavailability of drugs due to high
blood flow and permeability of oral mucosa is 4-
1000 times greater than that of skin 9
. FDOFs are
useful in patients such as pediatric, geriatrics,
bedridden, emetic patients, diarrhea, sudden
episode of allergic attacks, or coughing for those
who have an active life style. It is also useful
2. Ashok K A et al, ICJPIR 2016, 3(1), 11-21
www.icjpir.com
~12~
whether local action desired such as local
anesthetic for toothaches, oral ulcers, cold sores or
teething.
OTFs also have an established shelf life of 2-
3years, depending on the API but are extremely
sensitive to environmental moisture 10
.
The OTFs place as an alternative in the market
due to the consumer’s preference for a fast-
dissolving product over conventional tablets /
capsules. The oral thin-film technology is still in
the beginning stages and has bright future ahead
because it fulfills all the need of patients.
Eventually, film formulations having drug/s will be
commercially launched using the OTF technology
11
.
Oral thin films, a new drug delivery system for
the oral delivery of the drugs, were developed
based on the technology of the transdermal patch.
The delivery system consists of a very thin oral
strip, which is simply placed on the patient’s
tongue or any oral mucosal tissue, instantly wet by
saliva the film rapidly hydrates and adheres onto
the site of application. It then rapidly disintegrates
and dissolves to release the medication for oro
mucosal absorption or with formula modifications,
will maintain the quick-dissolving aspects allow for
gastrointestinal absorption to be achieved when
swallowed. In contrast to other existing, rapid
dissolving dosage forms, which consist of
liophylisates, the rapid films can be produced with
a manufacturing process that is competitive with
the manufacturing costs of conventional tablets.
AIM AND OBJECTIVES OF THE
STUDY
Aim
The aim of the present investigation is to
design, formulate and evaluate the oral
disintegrating films taking Sumatriptan as a model
drug to improve the bioavailability and providing
faster onset of action to relieve immediately acute
migraine attack.
Objectives
To carry out the pre formulation studies of
Sumatriptan.
To formulate mouth dissolving film containing
Sumatriptan.
To evaluate mouth-dissolving film, Weight
variation, Thickness, Folding endurance,
Disintegration time, Content uniformity and In
vitro dissolution studies.
To perform the stability studies for the
optimized formulation.
METHODOLOGY
Analytical methods
Calibration curve of Sumatriptan in 6.8pH
phosphate buffer
From the standard stock solution (1000 μg/ml),
appropriate aliquot were transferred to series of 10
ml volumetric flasks and made up to 10 ml with
buffer so as to get concentration of 2, 4, 6, 8, 10
μg/ml. the absorbance of the solution were
measured at 282 nm. This procedure was performed
in triplicate to validate calibration curve.
General method of formulation of oral thin
films3
Following processes are generally used to
manufacture the oral thin film: hot melt extrusion,
solid dispersion extrusion, rolling, semisolid
casting and solvent coating. The current preferred
manufacturing process for making this film is
solvent casting method. Water-soluble polymers
are completely dissolved in a mixing tank to form a
homogeneous viscous solution. Other ingredients,
including active ingredient are dissolved in a small
portion of aqueous solvent using a high shear
processor. The active mixture is then added to the
viscous colloidal solution to form a homogeneous
viscous solution. This viscous solution is degassed
under vacuum. The resulting bubble free solutions
poured onto glass mould and were kept in oven.
Dried film is then cut into the desired shape and
size for the intended application.
Dose calculations
Diameter of the plate = 6 cm
Area of the plate = 28.6 cm2
No. of 2.25 cm2
films present in whole plate =
28.6/2.25 = 12.7
Each film contains 25 mg of drug
12.7 no. of films contains mg of drug? = 12.7x5=
317.5 mg
3. Ashok K A et al, ICJPIR 2016, 3(1), 11-21
www.icjpir.com
~13~
The amount of drug added in each plate was
approximately equal to 318 mg.
Preparation of Oral thin film
Film was prepared by using specified polymer
by solvent casting method. The specified amount of
polymer was weighed and dissolved in specified
amount of water for overnight to get a uniform
dispersion of 4 % and 5 % (w/v) solution
respectively. Drug, cross carmellose sodium,
aspartame, citric acid were dissolved in specific
amount of water in a beaker. The drug solution was
added to the polymer solution and mixed using
magnetic stirrer for 1 hour. The resulting solution
was degassed so as to remove any bubbles formed.
The bubble free solution was casted on to a
petri dish of surface area 28.6 cm2
. It was dried for
24 hours at room temperature. The film was
removed from the petri dish very carefully and
observed for any imperfections. Film that was clear
and bubble free was selected for further studies.
Film of area 2.25 cm2
( 1.25 X 1.25 ) was cut and
stored in a butter paper coved with aluminum foil
and stored in a desiccator.
Table no 1: Composition of various oral thin film formulations
S no Ingredients
(mg/film)
F1 F2 F3 F4 F5 F6
1 Sumatriptan 25 25 25 25 25 25
2 CMC* 4 5 - - - -
3 PVA* - - 4 5 - -
4 HPMC* (15cps) - - - - 4 5
6 CCS 2 2 2 2 2 2
7 PG** 20 20 20 20 20 20
8 Aspartame 1 1 1 1 1 1
9 Sodium saccharine 1 1 1 1 1 1
10 Water Qs qs qs qs qs qs
* = Expressed as %w/v
** = Expressed as %w/w of the polymer
RESULTS AND DISCUSSION
Preformulation studies
The following preformulation studies were
performed for Sumatriptan
Solubility
Slightly soluble in water.
Determination of pH
Sumatriptan 4% W/V solution in water showed
pH around 7
Melting point
Melting point of the Sumatriptan was found to
be 170.20
C
Analytical methods
Standard Stock solution
100 mg of Sumatriptan was dissolved in 100 ml
of 6.8 phosphate buffer (1000 μg/ml).
Calibration curve of Sumatriptan in 6.8
phosphate buffer
From the standard stock solution (1000 μg/ml),
appropriate aliquot were transferred to series of 10
ml volumetric flasks and made upto 10 ml with
buffer so as to get concentration of 2, 4, 6, 8, 10
μg/ml. the absorbance of the solution were
measured at 282 nm. This procedure was performed
in triplicate to validate calibration curve. A
calibration curve was plotted.
4. Ashok K A et al, ICJPIR 2016, 3(1), 11-21
www.icjpir.com
~14~
Table no 2: calibration curve plot
S.No Concentration in μg/ml Absorbance
1 0 0
2 2 0.015
3 4 0.040
4 6 0.058
5 8 0.076
6 10 0.099
Fig No: 1 standard graph
Drug polymer compatibility studies
Fig No 2: FT-IR spectrum of sumatriptan
y = 0.0097x
R² = 0.9961
0
0.02
0.04
0.06
0.08
0.1
0.12
0 2 4 6 8 10 12
5. Ashok K A et al, ICJPIR 2016, 3(1), 11-21
www.icjpir.com
~15~
Fig No 3: FT-IR spectrum of final formulation using HPMC E 15 (FV)
Evaluation of oral thin films
Oral thin films were evaluated for the following
parameters.
Weight variation
Thickness of film
Folding endurance
Disintegration time
Mouth dissolving time
Content uniformity
Invitro dissolution studies
Weight variation of the films
Three Films each of 0.35 square inch were cut
at three different places from casted films and
weight variation was measured. Weight variation
varies from 61.4 ± 0.51 to 76.16 ± 0.87. The results
of weight variations are shown in the Table-3.
Table-3 Comparative evaluation of Weight variation of oral thin films
S.NO Formulation code Average weight of the 0.35 square inch film in mg Mean ± SD*
Trial 1 Trial 2 Trial 3
1 I 62.6 61.58 62.0 62.06 ± 0.51
2 II 74.80 64 75.75 74.75 ± 0.56
3 III 63.8 63.2 64.4 63.8 ± 0.6
4 IV 76.4 75.2 76.9 76.16 ± 0.87
5 V 61 61.8 61.4 61.4 ± 0.43
6 VI 72.3 72.8 71.5 72.2 ± 0.65
*Standard deviation, n =3
6. Ashok K A et al, ICJPIR 2016, 3(1), 11-21
www.icjpir.com
~16~
Thickness of the film
The thickness of the film was measured using
digital Vernier Calliper with a least count of 0.01
mm at different spots of the film. The thickness
was measured at three different spots of the film
and average was taken and SD was calculated. It
was observed that as the polymer concentration
increases the thickness of the film also increases.
Table-4 Comparative evaluation of Thickness of oral thin films
S.NO Formulation code Average thickness in mm Mean ± SD*
Trial 1 Trial 2 Trial 3
1 I 0.23 0.25 0.20 0.22 ± 0.025
2 II 0.28 0.30 0.30 0.29 ± 0.01
3 III 0.18 0.19 0.19 0.18 ± 0.00
4 IV 0.21 0.24 0.24 0.23 ± 0.01
5 V 0.08 0.10 0.12 0.1 ± 0.02
6 VI 0.15 0.18 0.15 0.16 ± 0.01
*Standard deviation, n =3
Tensile strength of the films
Tensile strength measures the ability of the film
to withstand rupture. The formulation FII shows the
maximum value of tensile strength 4.32 ± 0.02 and
folding endurance was 181 (no of folds) This might
be due to the formation of strong hydrogen bonds
between polymer and plasticizer there by imparting
flexibility to withstand rupture. Tensile strength of
the films was recorded in the Table-5
Table-5 Comparative evaluation of Tensile strength of oral thin films
S.NO Formulation code Tensile strength in MPa Mean ± SD*
Trial 1 Trial 2 Trial 3
1 I 3.85 3.80 3.85 3.83 ± 0.02
2 II 4.35 4.30 4.35 4.32 ± 0.02
3 III 3.10 2.98 3.1 3.06 ± 0.06
4 IV 3.28 3.30 3.30 3.29 ± 0.01
5 V 1.80 1.82 1.80 1.80 ± 0.01
6 VI 2.10 2.15 2.12 2.12 ± 0.02
*Standard deviation, n =3
7. Ashok K A et al, ICJPIR 2016, 3(1), 11-21
www.icjpir.com
~17~
Fig No 4: Tensile strength of Oral thin formulations
Folding endurance of the films
The folding endurance was measured manually
.A strip of film 4squre cm was cut and subjected
for the folding endurance studies until it broke at
the same place. Folding endurance increases with
increase in polymer concentration. The no of times
the film fold until it broke was reported in the
Table-6
Table-6 Comparative evaluation of folding endurance of oral thin films
S.NO Formulation code Folding endurance (no of folds) Mean±SD*
Trial 1 Trial 2 Trial 3
1 I 160 158 163 160 ± 2.15
2 II 178 185 180 181 ± 3.60
3 III 115 128 130 124 ± 8.14
4 IV 150 168 170 162 ± 11.01
5 V 90 93 102 95 ± 6.25
6 VI 110 105 117 110 ± 6.02
*Standard deviation, n =3
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
I II III IV V VI
tensilestrength
formulation code
8. Ashok K A et al, ICJPIR 2016, 3(1), 11-21
www.icjpir.com
~18~
Fig No 5: Folding endurance of oral thin films
Disintegration time
The disintegration time of the film was done by
using tablet disintegration test apparatus.
Disintegration times of the films were found to be
increased with increase in the concentration of the
polymer. The formulation FV shows 33 Sec
(disintegration time) as shown in the table 7.
Table-7 Comparative evaluation of Disintegration time of oral thin films
S.NO Formulation code Disintegration time in Sec Mean ± SD*
Trial 1 Trial 2 Trial 3
1 I 46 44 48 46 ± 2
2 II 52 54 56 54 ± 2
3 III 41 43 42 42 ± 1
4 IV 44 46 46 45.33 ± 1.15
5 V 34 30 36 33.33 ± 3.05
6 VI 45 48 46 46.33 ± 1.52
0
20
40
60
80
100
120
140
160
180
200
I II III IV V VI
foldingendurance
formulation code
9. Ashok K A et al, ICJPIR 2016, 3(1), 11-21
www.icjpir.com
~19~
Fig no 6: Disintegration time of oral thin films
Mouth dissolving time
The mouth dissolving time was determined by
using beaker containing 6.8-pH phosphate buffer.
A size of 0.35 square inch film was subjected for
this study. The mouth dissolving time of the film
was reported in the Table-8.
Table-8 Comparative evaluation of Mouth dissolving time of oral thin films
S.NO Formulation code Mouth dissolving time in Sec Mean ± SD*
Trial 1 Trial 2 Trial 3
1 I 54 55 52 53.6 ± 1.52
2 II 64 68 62 64.66 ± 3.05
3 III 47 49 45 47 ± 2
4 IV 52 58 56 55.33 ± 3.05
5 V 40 38 44 40.66 ± 3.04
6 VI 49 55 54 52.66 ± 3.21
*Standard deviation, n =3
Drug content uniformity of films
The prepared film formulations were analyzed
for drug content and it was observed that all the
formulation found to contain almost uniform
quantity of drug as per content uniformity studies
indicating reproducible technique. The data is
reported in the table-9.
Table-9 Results of drug content uniformity of oral film formulations
S.NO Formulation code Drug content in mg Mean ± SD*
Drug content
Trial 1 Trial 2 Trial 3
1 I 24.85 24.96 25.1 24.97 ± 0.12 99.4 %
2 II 24.9 24.95 24.9 24.91 ± 0.02 98.2 %
0
10
20
30
40
50
60
I II III IV V VI
disintegrationtime
formulation code
10. Ashok K A et al, ICJPIR 2016, 3(1), 11-21
www.icjpir.com
~20~
3 III 24.8 24.75 24.8 24.78 ± 0.02 95.6 %
4 IV 24.8 24.82 24.79 24.79 ± 0.03 95.8 %
5 V 24.9 24.85 24.92 24.86 ± 0.02 97.2 %
6 VI 24.79 24.83 24.92 24.84 ± 0.06 96.8 %
*Standard deviation, n =3
Each film contain 25 mg / 0.35 inch2
In-vitro dissolution
The dissolution study was carried out using
USP Type I (Basket type) dissolution apparatus.
The dissolution was carried out in 500 ml of pH 6.8
phosphate buffer maintained at 37 ± 0.50
C at 50
rpm. 5 ml aliquots of samples were taken at various
time intervals which were replaced with same
volume of fresh pH 6.8 phosphate buffer
maintained at 37 ± 0.50
C. Sumatriptan in the
samples was then determined
spectrophotometrically at λmax of 282 nm. The
results were expressed in table no 10.
Table-10 Comparative evaluation of Invitro dissolution profiles of oral thin Films
SNO Time in min Cumulative % of drug release
FI FII FIII FIV FV FVI
1 2 26 % 22.6% 22% 21% 45% 41%
2 4 53.3% 45.9% 49.3% 39.8% 77.3% 69.3%
3 6 78.3% 71% 69% 56% 98.5% 90.9%
4 8 93.2% 85.3% 80% 81% 98.5% 96.8%
5 10 96.3% 92% 92.4% 92.4% 98.5% 96.8%
6 12 97.3% 93.9% 94.5% 96% 98.5% 96.8%
7 14 98.4% 94.9% 97% 97.3% 98.5% 96.8%
8 16 98.6% 96.1% 97% 98% 98.5% 96.8%
9 18 98.6% 97.2% 97% 98% 98.5% 96.8%
10 20 98.6% 98 97% 98% 98.5% 96.8%
Fig no 7: Dissolution profile of Oral thin films
0
20
40
60
80
100
120
0 5 10 15 20 25
CUMULATIVE%DRUGRELEASE
TIME IN SECS
F1
F2
F3
F4
F5
F6
11. Ashok K A et al, ICJPIR 2016, 3(1), 11-21
www.icjpir.com
~21~
CONCLUSION
From the present investigation it can be
concluded that oral thin film formulation can be a
potential novel drug dosage form for pediatric,
geriatric and also for general population.
BIBLIOGRAPHY
[1]. Ishikawa T, Koizumi N, Mukai B. Pharmacokinetics of acetaminophen from rapidly disintegrating
compressed tablet prepared using microcrystalline cellulose (PHM06) and spherical sugar granules. Chem
Pharm Bull (Tokyo) 2001; 49: 230-32.
[2]. Price TM, Blauer KL, Hansen M, Stanczyk F, Lobo R, Bates GW. Singledose pharmacokinetics of
sublingual versus oral administration of micronized 17 beta estradiol. Obstet Gynecol 1997; 89: 34045.
[3]. R.P Walton Absorption of drugs through the oral mucosa. III Fat water solubility coefficient of alkaloids.
Proc Soc Exp Bio Med 1935; 32: 1488.
[4]. Kurosaki Y, Takatori T, Nishimura H, Nakayama T, Kimura T . Regional variation in oral mucosal drug
absorption permeability and degree of keratinization in hamster oral cavity. Pharm Res 1991; 8: 1297-
1301.
[5]. Ghosh TK, Chatterjee DJ, Pfister WR. Quick dissolving oral dosage forms: Scientific and regulatory
considerations from a clinical pharmacology and biopharmaceutical perspective. In: Ghosh TK and Pfister
WR (Eds). Drug Delivery to the Oral Cavity Molecules to Market. NY, USA: CRC Press, 2005: 337-356.
[6]. Boer D et al. Drug absorption by sublingual and rectal routes. British J Anaesthesia 1984; 56: 69-82.
[7]. Mary Elizabeth RN, Martelli BS. Sublingual and buccal medication administration. Encyclopedia of
Nursing and Allied Health, 20050229
[8]. Lea L. Sublingual Administration. Colon Health 1996; 13.
[9]. Galey, W.R., H.K. Lonsdale and S. Nacht, 1976. The in vitro permeability of skin and buccal mucosa to
selected drugs and tritiated water. J. Investigative Dermatol., 67(6): 713-717.
[10]. Malke, M., S. Shidhaye and V.J. Kadam, 2007. Formulation and evaluation of Oxacarbazine fast dissolve
tablets. Indian J. Pharmaceutical Sci., 69(2): 211-214.